Výsledky vyhledávání

Comparison of different routes of administration of nadroparin in hemodialysis

Autor: Vanuytsel, J. L., Lins, R. L., Zachée, P., Mattheeussen, J., Hosten, S., Lens, S., Daelemans, R.

Publikováno v: Europe PubMed Central
Scopus-Elsevier

In an open, crossover, randomized study in hemodialysis patients, we investigated possible differences of the effect of the low molecular weight heparin (LMWH) nadroparin/fraxiparine in relation to the route of administration.The effect of nadroparin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d45b9b10f323079e590d4402d4c29cd1
https://pubmed.ncbi.nlm.nih.gov/10584996

Zobrazit plný text záznamu

Hypertension and accelerated atherosclerosis in endstage renal disease

Autor: Huysmans, K., Lins, R. L., Daelemans, R., Zachée, P., Broe, M. E.

Publikováno v: Journal of nephrology
Europe PubMed Central
Scopus-Elsevier

In patients with chronic renal failure cardiovascular morbidity and mortality are higher than in non-uremic controls. Chronic renal failure influences a number of factors that promote atherogenesis: blood pressure, nitric oxide activity, advanced gly

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::fb767e4b2e7b4feeb28378a329a31c63
https://hdl.handle.net/10067/199590151162165141

Zobrazit plný text záznamu

Treating hypertensive patients with intracranial pathology

Autor: Malbrain, M L, Wyffels, E, Lins, R L, Daelemans, R

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3848::d25f7aa61bf9a396249b974551c35218
https://hdl.handle.net/20.500.14017/3832489e-bde3-4519-be6e-6cacfea1a60a

Zobrazit plný text záznamu

Long-term efficacy and safety of a low molecular weight heparin in chronic hemodialysis patients. A comparison with standard heparin

Autor: Nurmohamed, M T, ten Cate, J, Stevens, P, Hoek, J A, Lins, R L, ten Cate, J W

Publikováno v: Nurmohamed, M T, ten Cate, J, Stevens, P, Hoek, J A, Lins, R L & ten Cate, J W 1991, ' Long-term efficacy and safety of a low molecular weight heparin in chronic hemodialysis patients. A comparison with standard heparin ', ASAIO transactions / American Society for Artificial Internal Organs, vol. 37, no. 3, pp. M459-61 .
ASAIO transactions / American Society for Artificial Internal Organs, 37(3), M459-61. American Society For Artificial Internal Organs

The efficacy and safety of a low molecular weight heparin (LMWH) given as a single predialysis bolus injection was compared to standard heparin (SH) administered with a continuous infusion in a randomized, 6 month, open follow-up study in 70 patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d5854f41866174ca5cdb317ddfb39c49
https://research.vumc.nl/en/publications/ba0b1c8a-c331-4c93-8f31-e357d3560fb2

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání